Pre-market hot trades in US stocks: Livewire up 3.86% pre-market; Banco Santander SA-Spon up 3.81% pre-market
I'm LongbridgeAI, I can summarize articles.Livewire pre-market up 3.86%; Banco Santander SA-Spon pre-market up 3.81%; Nuwellis pre-market up 98.44%; T3 Defense pre-market up 77.22%; China Su Xuan Tang Pharmaceutical pre-market up 61.52%
Popular Pre-Market Trades in US Stocks
Livewire is up 3.86% in pre-market trading. Based on recent key news:
-
On July 28, LiveWire reported that its market share in the US electric motorcycle market over 50 kW reached 76%, and the net cash usage in operational activities improved by 18%, driving the stock price up. Source: Benzinga
-
On July 29, LiveWire received a notice from the NYSE regarding non-compliance with listing rules related to trading stock prices, which may negatively impact the stock price. Source: Reuters
-
On July 29, analysts rated LiveWire's technical sentiment signal as a sell, and the market is cautious about its future performance. Source: MarketBeat The competition in the electric motorcycle industry is intensifying, and market volatility is significant.
Banco Santander SA-Spon is up 3.81% in pre-market trading. Based on recent key news:
-
On July 28, State Street Bank announced the acquisition of Santander Group's securities services business in Latin America, expanding its business footprint in the region. This transaction will enhance Banco Santander's market position and drive the stock price up.
-
On July 27, several analysts maintained a buy rating on Banco Santander and set a higher target price, boosting market confidence and driving the stock price up.
-
On July 28, Spanish regulators launched an antitrust investigation into Banco Santander and other major lending institutions. Although this brings legal uncertainty, it did not prevent the stock price from rising. The financial industry faces risks of interest rate compression.
Top Gainers in Pre-Market Trading in US Stocks
Nuwellis is up 98.44% in pre-market trading. Based on recent key news:
-
On July 27, Nuwellis announced a preliminary revenue growth of 14% for the second quarter of 2026, significantly boosting the stock price. The company stated that this growth was mainly due to the commercial success of the Aquadex ultrafiltration platform. Source: Reuters
-
On July 27, Nuwellis announced a year-on-year revenue growth of 20% for the first half of 2026, further enhancing market confidence. Source: Public Technologies
-
On July 27, Nuwellis is expected to release its complete financial results for the second quarter on August 13, and the market is looking forward to it. Source: Public Technologies The medical device industry is experiencing strong growth, and market attention is high.
T3 Defense is up 77.22% in pre-market trading. Based on recent key news:
-
On July 29, T3 Defense completed a 1-for-125 reverse stock split, reducing the float to 1.12 million shares, and a technical short squeeze triggered a sharp rise in the stock price. The company made progress in its Project 35 in the anti-drone technology field, successfully delivering contracts, further boosting market confidence. Source: Benzinga
-
On July 28, T3 Defense's subsidiary completed the delivery of an automated composite material production line to a major Israeli manufacturer, valued at $1.1 million, expanding its influence in the high-demand anti-drone technology sector. Source: Benzinga
-
On July 28, X S.E. Security and Defense Ltd. acquired a 16.67% stake in T3 Defense in exchange for equity in Project 35, with the strategic investment news boosting investor confidence. Source: Benzinga Demand for anti-drone technology is increasing, and the market is active.
China Su Xuan Tang Pharmaceutical, pre-market up 61.52%, has no significant news recently. Trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation
